Unraveling the pathophysioiogy of IgE-mediated allergic disorders requires a thorough understanding of the complex mechanisms that control IgE antibody synthesis. The selective activation and further maturation of the IgE B cell are regulated by both antigen-specific and non-antigen-specific, but isotype-restricted, T cells and the soluble factors that they produce (1-6). Although the manner by which antigen-specific and isotype-restricted regulatory events are coordinated is still unresolved, studies of Ishizaka and colleagues (7-13) and of our group (14-19) indicate that the Fc determinants of IgE and the correspondingly specific Fc receptors for IgE (FcR~) ~ on lymphocytes contribute significantly to such regulatory mechanisms.
The experimental manipulation of a given type of immune response, either by eliminating the relevant B or T cell components early in their development or by provoking the development of negative control mechanisms early in ontogeny, has always yielded valuable information about the immune system (24, 25) . Recently, we have described a phenomenon in which neonatal treatment of mice with soluble or cell-bound monocional IgE molecules results in the development of profound IgE class-restricted immunodeficiency (26) . Such findings indicate that some cellular component(s) associated with the IgE antibody system, possibly capable of reacting specifically with ~ determinants of IgE heavy chains (e.g., FcR~ + cells), are perturbed when confronted by IgE at an early stage of development; this early perturbation manifests itself in adulthood as persistent unresponsiveness in the IgE antibody class.
In the present report, we have further explored the IgE class-restricted tolerance model in order to develop some understanding of the mechanisms underlying defective IgE antibody synthesis in this system. Herein, we demonstrate that (a) the IgE class-restricted tolerance-inducing signal is, indeed, conveyed by the Fc domain(s) of IgE molecules; (b) the ability to develop isotyperestricted tolerance appears to be unique to the IgE antibody system, since neonatal treatment with other immunoglobulin (Ig) isotypes, which as IgA or IgG, does not result in corresponding isotype-restricted immunodeficiency; (c) spleen cells from IgE isotype-tolerant mice fail to express FcRE following stimulation in vitro with monoclonal IgE, a defect that distinguishes such tolerant mice from their normal control counterparts; and (d) neonatal treatment with soluble IgE generates IgE class-specific suppressor T ceils whose activity can be readily demonstrated in adoptive transfer experiments, whereas tolerance induction with cell-bound IgE appears to involve a different mechanism, the nature of which is unresolved.
Materials and Methods

Reagents
Proteins and Chemicals. The following materials employed were from commercial sources: 2,4,6-trinitrobenzene sulfonic acid (TNBS; ICN Pharmaceuticals, Cleveland, OH); keyhole limpet hemocyanin (KLH; Pacific Bio-Marine Co., Venice, CA); bovine serum albumin (BSA), ovalbumin (OVA), and dithiothreitol (DTT) (Sigma Chemical Co., St. Louis, MO); CNBr-activated Sepharose-4B and N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP) (Pharmacia Fine Chemicals, Uppsala, Sweden). DNP28-BSA was prepared as previously described (27) .
Monoclonal and Conventional Antibody Reagents. Monoclonal anti-DNP antibodies of the IgE, IgG1, and IgG2b classes were obtained and purified from hybridomas constructed and characterized previously (27) ; that of the IgA class was from a myeloma line, MOPC 315. The ragweed (RAG)-specific IgE monoclonal antibody was obtained and purified as described recently (28) . Rabbit anti-mouse IgA (RAMA) was purchased from Litton Bionetics, Kensington, MD. Other conventional antibodies were prepared in our laboratory and purified by affinity chromatography on specific immunoadsorbent columns. These included murine anti-KLH specific antibodies, rabbit anti-mouse IgG (RAMG), rabbit anti-mouse IgE (RAME), goat anti-rabbit immunoglobulin (GARG), rabbit anti-KLH, and rabbit anti-BSA.
Animals
(BALB/c × SJL)Fj mice were obtained from the breeding colonies in the animal quarters of the Medical Biology Institute. Parental strains of female BALB/c and male SJL mice were purchased from The Jackson Laboratory, Bar Harbor, ME. Adult male Lewis rats were obtained from Holtzman Co., Madison, WI.
Covalent Conjugation of Monoclonal Antibodies to Splenocytes with the Heterobifunctional Reagent, SPDP
The procedure was described in detail previously (26) . Briefly, 50 #1 of freshly prepared solution (20 mM) of SPDP was added to 1 mi solution of DNP-specific monoclonal IgE, IgG1, IgG2b, or IgA (1 mg/ml) in phosphate-buffered saline, pH 7.5 (PBS). The mixture was stirred gently for 30 min at room temperature (r.t.), then the excess SPDP reagent was removed by dialysis, and the resulting 3-(2-pyridyldithio) propionyl protein derivative (PDP-protein) was recovered. To generate active sulfhydryl groups on the splenocyte surface, 0.5 ml of 0.01 M DTT was added to 10 ml of 2% spleen cell suspension and the mixture was incubated at r.t. for 1 h. The DTT-treated cells were washed thoroughly with PBS, resuspended in 10 ml of PBS, and then reacted with PDP-proteins (1 mg/ml, 10 mi) at r.t. for 1 h. Protein-coupled splenocytes were washed twice in PBS and resuspended at appropriate concentrations in saline for injection. The quantity of IgE molecules coupled to spleen cells was determined by radiolabeling tracer studies using 125I-labeled PDP-IgE (26) .
Adoptive Transfer System
The adoptive transfer system employed for IgE antibody responses was as described by Hamaoka et al. (29) . Briefly, donor mice for KLH-immune spleen cells were prepared by immunizations with 1 #g KLH in 2 mg alum injected intraperitoneally (i.p.) at 2-3 wk intervals. In an adoptive transfer, 15 x 108 KLH-immune spleen cells together with 30 x 106 spleen cells, B cells, or T cells, prepared from mice treated neonatally with IgE or control materials, were injected intravenously to syngeneic recipients, which had been irradiated (650 rad) in a ISTcesium irradiator on the same day. Immediately after cell transfer, recipients were boosted with 1 #g KLH in 2 mg alum. Mice were bled 7 and 14 d later, and their sera assayed for KLH-specific IgG and IgE antibodies.
Assessment of Antibody Responses
Measurement ofAnti-KLH IgA Antibodies. KLH-specific IgE antibody levels in pools of sera from each group were determined by passive cutaneous anaphylaxis (PCA) reactions, using male Holtzman rats as described in detail (29, 30) .
Measurement of Anti-KLH IgG and lgA Antibodies. KLH-specific IgG and IgA antibody levels in individual sera, were determined by a solid-phase radioimmunoassay (RIA) system in which serum samples were allowed to react with KLH on solid-phase, and then detected with either RAMG or RAMA, followed by 1~SI-labeled GARG as previously described in detail (26, 27) . For measuring IgA, DNP-specific MOPC 315 IgA myeioma proteins were used as standards. Geometric means and standard errors were obtained from at least four individual mice in each group. Statistical differences were derived by Student's t test between treated and control groups.
Preparation of T Cell-and B Cell-enriched Lymphocyte Populations
T cell-enriched lymphocytes were prepared by the nylon wool method (31) . B cellenriched lymphocytes were prepared by treating lymphocytes twice sequentially with antiThy-l.2 ascites (C3H anti-AKR) plus C as previously described (32) .
In Vitro System for Induction of FcRe + Lymphocytes
The procedure was described in detail (14) . Briefly, l0 T splenic lymphocytes from (BALB/c × SJL)F~ mice, neonatally treated with IgE or control materials, were cultured in vitro in the presence of monoclonal antibodies at varying final concentrations for various lengths of time. Triplicate cultures were pooled, washed twice, and resuspended 7 + at 5 × 10 cells/ml. FcRe lymphocytes were detected as cells that form rosettes with IgEcoated sheep erythrocytes (SRBC; reference 33) as described previously (14) .
Results
Induction of IgE Class-restricted Tolerance by Neonatal Exposure of (BALB/c x SJL) F~ Mice to Soluble Monoclonal IgE Antibodies of Two Distinct Antigen Specificities.
(BALB/c x SJL)FI mice were injected i.p. with various doses of DNPspecific or RAG-specific monoclonal IgE antibodies from 0.25 #g to 250 ~g per injection on day 0 and day 6 after birth in 50 #I saline and in 100 #1 saline on day 13 and day 37. Control mice were treated with saline. At 3 months of age, these mice were immunized i.p. with 1 #g of KLH in 2 mg of alum and boosted likewise on day 10 and day 24 thereafter; 10 d after the third immunization, sera were collected and analyzed for KLH-specific IgE and IgG antibody respouses.
Three points can be made from the results of this experiment, summarized in Fig. 1 . First, as shown in A, IgE-restricted tolerance was induced with as little as 2.5 #g of soluble IgE per injection; this dose is 100-fold less than the 250 #g of soluble IgE used in our first report (26) .
Second, the tolerance-inducing property resides in the constant region of the heavy chain. Thus, despite the fact that DNP-specific and RAG-specific monoclonal IgE antibodies have very different antigen-binding specificities, they are equally effective in inducing IgE-restricted tolerance over a 3 log dose range. Third, this tolerance is restricted to the IgE antibody system, since KLH-specific IgG antibody responses were not significantly different between saline-treated or IgE-treated mice (B).
IgE Class-restricted Tolerance Can Be Induced by Neonatal Exposure of (BALB/c x SJL)F1 Mice to Subnanogram Quantities of Syngeneic Cell-bound IgE. Previously,
IgE class-restricted tolerance was induced with 25-50 x 106 IgE-conjugated cells carrying 5-10 ng of monoclonal IgE per injection (26) . Since results in Fig. 1 document that tolerance can be induced with considerably less soluble IgE than heretofore realized, the following experiment was conducted to determine the minimum quantity of cell-bound IgE required for tolerance induction.
(BALB/c X SJL)FI mice were injected i.p. with various numbers, ranging from 1 to 50 × 106, of DNP-specific IgE-conjugated, or control untreated, syngeneic spleen cells on day 0 and day 10 after birth in 50 #1 saline and on day 17 in 100 #1 saline. At 2 months of age, they were immunized i.p. with 1 #g of KLH in 2 mg of alum and boosted on day I0 and day 24 thereafter. Sera of these mice were collected on day 34, i.e., 10 d after the third antigen immunization, and analyzed for KLH-specific IgE and IgG antibody responses.
As shown in Fig. 2 , all three control groups developed both IgE and IgG antibody responses irrespective of whether they were sham-treated perinataily with saline (group I) or with two different doses of unconjugated syngeneic spleen cells (groups II and III). In contrast, mice treated with IgE-conjugated cells were selectively unresponsive, in the IgE class, even at the lowest cell number employed (1 x 106), which corresponds to an absolute amount of 0.2 ng of monoclonal IgE per injection. Thus, by comparison to the results presented in Fig. 1 , where at least 2.5 #g of soluble IgE per injection was required for induction of IgE class-restricted tolerance, cell-bound IgE is effective at a dose 104 lower than the amount of soluble IgE needed to accomplish the same results. (14), we demonstrated that exposure of normal mouse splenic lymphocytes to appropriate concentrations of monoclonal IgE in vitro resulted in the induction of significant numbers of cells expressing IgE-specific Fc receptors, or FcR~. Indeed, these observations, together with the demonstrated ability to modulate such FcR~ expression by concomitant exposure of the same cultures to the IgE classrestricted regulatory molecule, suppressive factor of allergy (SFA), prompted us to initiate the present series of experiments (26) . Since the hypothesis leading to the design of such experiments was that FcR~ + lymphocytes played important regulatory roles in the IgE antibody system, it was thus pertinent to examine whether mice treated perinatally with IgE, and rendered tolerant in the IgE class-restricted fashion, displayed abnormal cellular behavior with regard to in vitro induction of FcR~ + lymphocytes by exposure to monoclonal IgE.
Isotype-restricted Tolerance by Neonatal Exposure of (BALB/c × SJL)FI Mice to
INDUCTION OF IgE CLASS-RESTRICTED TOLERANCE BY NEONATAL EXPOSURE OF (BALB/c x SJL) Ft MICE TO DIFFERENT DOSES OF SOLUBLE MONOCLONAL
Monoclonal Antibodies Is Only Induced by IgE and Is
To make this analysis, the ability of spleen cells from (BALB/c X SJL)FI mice treated perinatally with monoclonal IgE to respond to IgE by expression of FcR~ was compared to parallel control groups of F1 mice. Thus, spleens of mice from groups receiving the same materials three to four times from the experiments described in Figs. 1-3 were used as sources of spleen cells for these studies. All mice, either controls or those treated perinatally with soluble or cell-bound IgE, had been immunized with 1 #g KLH in alum three times at 10-14 day intervals, and were rested for approximately 3 months at the time their spleen cells were removed for the FcR~ induction assay. Single cell suspensions were prepared from a pool of three spleens for each group. 
INDUCTION OF FcR + CELLS IN CULTURE OF (BALB/c x SJL)F t SPLEEN CELLS EXPOSED TO DIFFERENT DOSES OF MONOCLONAL DNP-SPEClFIC IgE
CONCENTRATION OF MONOCLONAL DNP-SPECIFIC ZgE ADDED TO CULTURE (#g/ml)
Neonatal Exposure of (BALB/c X SJL)Fx Mice to Soluble lgE Induces Persistent IgE Class-restricted Suppressor T Cells Transferable to Irradiated Adoptive Recipients.
The preceding experiment documented that induction of IgE class-restricted tolerance is accompanied by an inability of cells from such mice to develop FcRe+ cells upon in vitro exposure to monoclonal IgE. The absence of such inducible cells could be the direct cause of unresponsiveness in the IgE class, or this could be a secondary manifestation of some other mechanism underlying the unresponsive state. To ascertain whether suppressor cells may be involved in the described IgE-restricted tolerance, the following experiment was undertaken.
The protocol for this study is summarized on the left portion of Fig. 5 , with the corresponding data from each part of the experiment depicted on the right portion of the same figure. As outlined in the top section of the figure, (BALB/ c × SJL)F~ mice were treated on days 0, 7, and 17 after birth with either control or experimental material. Control material consisted of either saline or 50 x 106 unconjugated syngeneic spleen cells, while experimental material consisted of either soluble monoclonal IgE of two different specificities (anti-DNP and anti-RAG, 250 t~g per injection) or 50 × 106 IgE-conjugated syngeneic spleen cells. At 2.5 months of age, they were immunized with 1 t~g of KLH in 2 mg of alum and boosted on day 10 and day 24 thereafter. Mice were rested for 52 d and boosted with 1 t~g KLH in alum. 14 d later, all groups were bled, killed, and their spleens removed to be used as one source of donor cells in the adoptive cotransfer experiment described below. The data summarized in the top portion of Fig. 5 verify that those donor mice treated with either soluble or cell-bound monoclonal IgE displayed long-term IgE class-restricted tolerance that had persisted over a period of six months after receiving only three treatments during the first 3 wk of life.
The adoptive co-transfer experiment, which employed spleen cells from these tolerant mice and their corresponding controls, is summarized in the bottom portion of Fig. 5 . The spleens from these donors were pooled by group and prepared as single cell suspensions. Cells from donors treated neonatally with saline or with soluble DNP-specific monoclonai IgE were further fractionated on nylon wool columns to obtain a T cell-enriched fraction or treated with antiThy-l.2 plus C to obtain the B ceil-enriched fraction. 30 × 106 whole spleen cells, or T cell-enriched or B cell-enriched fractions were then co-transferred intravenously with 15 × 10 6 whole spleen cells from KLH-hyperimmunized syngeneic donor mice into 650 rad irradiated syngeneic recipients. All recipients were challenged i.p. with 1 ~g of KLH in alum and bled 14 d later to assess the resulting IgE anti-KLH antibody responses.
Whole spleen cells from donor mice tolerized by soluble IgE, when injected alone into irradiated recipients, failed to develop IgE anti-KLH antibody responses upon antigen challenge (Table I, Spleen cells from donor mice treated neonatally with unconjugated syngeneic spleen cells developed good IgE anti-KLH antibody responses when they were adoptively transferred alone into irradiated recipients, while donor cells from mice treated with IgE-conjugated cells failed to develop such responses (Table I , groups IV and V). However, as shown in Fig. 5 , co-transfer of each of these donor cell types with KLH-hyperimmune spleen cells resulted in equivalent adoptive secondary IgE antibody responses (groups IV and V).
When B cell-and T cell-enriched fractions of spleens from donors treated 
IV Unconjugated spleen 640 V IgE-Conjugated spleen cells (DNP-specific) <10 * (BALB/c x SJL) F~ mice were treated with monoclonal IgE or control material on days 0, 7, and 17 after birth. At 2.5 months of age, they were immunized with 1 ~g of KLH in 2 mg of alum and boosted with I ~g KLH in alum. 14 d later, 30 x 106 whole spleen cells were injected into 650 rad irradiated syngeneic recipients and boosted with 1 t~g KLH in alum. 14 d later, mice were bled and the pooled sera were assessed for PCA responses.
neonataily with either saline or soluble DNP-specific IgE were examined for suppressive activities in this co-transfer system, neither cell type from salinetreated donors exerted any suppressive effects (groups VI and VII), and the T cell-enriched fraction actually caused a twofold enhancement of IgE responses. However, while the B cell-enriched fraction from the soluble IgE-treated donor spleen exerted no detectable effects on the adoptive secondary IgE response (group VIII), the T cell-enriched fraction from these same donor spleens completely abrogated the IgE anti-KLH secondary responses (group IX). It should be emphasized that all of the suppressive activities observed in this experiment (groups II, III, and IX) were selective for responses of the IgE class, since comparable responses among all groups were obtained in the IgG class (data not shown).
Discussion
The experiments presented herein further explored our previous observations on the phenomenon of IgE class-restricted tolerance induced by treatment of neonatal mice with soluble or cell-bound IgE (26) . The data obtained from these studies have established the following four points:
Point I. IgE class-restricted tolerance can be induced in this system by neonatal treatment with monocional IgE, irrespective of its antigen specificity, and the resulting effects appear to be polyclonal in nature since IgE responses specific for antigenic determinants unrelated to the tolerance-inducing IgE molecules are affected. Thus, monocional IgE antibodies specific for the DNP hapten, on one hand, and for determinants of ragweed antigen, on the other, were comparably effective in inducing this class-restricted tolerance. It is important that the ultimate IgE response tested in such mice as adults was directed to antigenic determinants--in this case, those present on the complex protein, KLH--completely unrelated to the inducing IgE molecules. This formally eliminates any possibility that our previous results (26) , which employed only DNP-specific monoclonal IgE, could have reflected some unsuspected relationships between the DNP-haptenic determinant with dominant determinants on the KLH molecule, and supports the polyclonal nature of this tolerance phenomenon. Moreover, these findings strongly support the likelihood that the molecular subregion(s) involved in inducing IgE class-restricted tolerance in the system resides in the Fc~ domain of the IgE molecule.
Although not known at present, it will ultimately be important to determine the precise Fc~ molecular subregion(s) responsible for inducing this tolerance. Liu et al. (34) have cloned the cDNA specifying the ~ heavy chain fragment of the monoclonal DNP-specific IgE employed in these studies. This cloned cDNA contains the coding regions for part of the C~I and all of the C,2, C~3, and C,4 domains of the IgE molecule. Comparisons with human IgE reveal that homologies of 36%, 47%, and 51% exist between mouse and human C~2, C~3, and C~4 domains, respectively (34, 35) . Two biological observations suggest that inductive signals conveyed by molecular regions in the FcE domains are highly conserved within the mouse and, possibly, between mouse and man: First, the murine DNP-specific IgE antibodies employed in these studies can induce expression of FcR~ on lymphocytes derived from unrelated strains (C57BL/6 and SJL) of mice (Chen and Katz, unpublished observations). Second, in the aggregated form, this same monoclonal IgE has been shown to induce expression of FcRE on human lymphoid cells (36) . Whether the conserved molecular subregions of Fce that induce expression of FcR~ on mouse and human lymphocytes, respectively, are the same as those responsible for inducing neonatal IgE class-restricted tolerance, in the system described herein, has yet to be determined. However, as will be discussed below, some suggestion of this derives from the finding that lymphoid cells from such tolerant mice are unresponsive to IgE-mediated FcRE expression.
Point 2. The induction of isotype-restricted tolerance by neonatal treatment with soluble or cell-bound immunoglobulin molecules appears to be a unique feature of the IgE antibody system. Thus, mice treated neonataily with soluble or ceil-bound IgA, IgG1, or IgG2b were perfectly capable of developing antibody responses of the IgA and IgG isotypes, respectively, when immunized as adults. This contrasts with the substantial unresponsiveness, in the IgE class only, manifested by mice treated neonatally with soluble or cell-bound IgE. The reasons for such differences are unknown, but do not necessarily infer something physiologically unique about the IgE system. Rather, since the IgE system is programmed to produce considerably lesser amounts of IgE antibody molecules than is true of other immunoglobulin isotypes, the system may be considerably more sensitive to perturbations conveyed by neonatal treatment in the manner employed in this system. (14) . Since recent studies in our laboratory have demonstrated that IgE-mediated in vitro induction of FcRe + lymphocytes reflects a cascade of events beginning with B lymphocytes and then subsequently proceeding to T lymphocytes (15) (16) (17) (18) (19) , this unresponsiveness to FcRe expression could only be at the B cell level in order to yield the results observed herein; however, it is not possible to determine whether such treatment affects only B cells or both B and T lymphocytes capable of expressing FcRe. In any case, the failure of tolerant spleen cells to express FcRe following in vitro induction of IgE could reflect one or more of the following events: first, exposure of immature FcRe+ cells to IgE during the neonatal period could result in irreversible negative modulation of such Fc receptors. Alternatively, such exposure could render such FcR~ + cells residually capable of expressing FcR,, but only at a low density that would then be insensitive to detection by the rosette assay employed. Second, neonatal exposure to IgE could induce suppressive regulatory cells which, when subsequently exposed to IgE, might prevent the development of FcRE÷ cells in this system. This is reminiscent of earlier observations reported by us demonstrating that the IgE-selective regulatory factor, suppressive factor of allergy (SFA) quite effectively inhibits IgE-mediated FcRe expression in vitro (14, 16, 19, 37) .
Although it is not possible at this time to draw conclusions about the relationship between lack of inducible FcRe+ cells and the IgE isotype-restricted tolerance phenomenon, we believe that the corollary observations are important and very likely related to one another. Considerable evidence has been recently accumulated indicating that FcR ÷ cells participate significantly in regulating isotypespecific antibody responses. Suppressor T cells and their released soluble products, some of which are immunoglobulin-binding factors (IBF), that selectively inhibit synthesis of IgG~, IgG~a, and IgG2b have been demonstrated by other investigators (38, 39) . Similarly, in the IgA system FcRo~ + T cells generated in high quantities in IgA myeloma-bearing mice, have been shown to regulate the synthesis of IgA (40) . In the IgE system, FcRe ÷ cells, and their secreted soluble products, have been shown to positively or negatively regulate various aspects of the IgE antibody system (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) 37) .
Interestingly, the experimental system described herein reveals an insensitivity, relative to that observed with IgE, to neonatal perturbation by administration of IgA, IgG1, or IgG2b. As mentioned above, this could reflect the substantial differences in magnitudes of IgE immunoglobulin levels produced in the normal situation as contrasted to quantities of other immunogiobulin isotypes. (Table I) . Although IgE class-specific suppressor cells cannot be demonstrated by co-adoptive celt transfer techniques (Fig. 5) , it is possible that cell-bound IgE may be able to elicit suppressor T cells which, together with suppressive factors that they may produce, could maintain the unresponsive phenotype in situ.
On the other hand, mice treated neonatally with soluble IgE are unresponsive to in situ antigen challenge, but also possess IgE class-restricted suppressor T cells demonstrable in adoptive transfer circumstances. It is possible that neonatal treatment with soluble IgE more effectively generates transferable suppressor T cells as a result of an interaction between fluid-phase IgE and FcR~ + precursor cells resulting in an IgE-FcR~ + cell surface complex which, in turn, may induce second-order suppressive regulatory cells. Since FcR~ + cells cannot be induced in lymphoid populations from such tolerant mice, we favor the interpretation that these second-order suppressor cells, once induced, may be maintained in such animals and actively suppress the development of IgE antibody-forming cells and/or IgE Class-specific helper T cells via receptors directed against the FcR~ itself.
This experimental system of IgE isotype-restricted tolerance provides a different avenue for exploring the composition and complex cellular interactions regulating the IgE antibody system. Delineating the precise tolerance-inducing molecular sites on the IgE molecule and the mechanism by which tolerogenic signals are delivered could ultimately help to unravel molecular mechanisms controlling IgE antibody synthesis and, perhaps, synthesis of other immunoglobulin isotypes as well.
Summary
Certain aspects of the phenomenon of IgE class-restricted tolerance induced in mice by neonatal treatment with monoclonal IgE, either in soluble form or coupled to syngeneic spleen cells, were examined. The present studies document that this tolerance results from exposure to IgE molecules, irrespective of their antigen specificity, and the resulting effects are polyclonal in nature since IgE responses directed against antigenic determinants unrelated to the toleranceinducing IgE molecules are affected. Moreover, such findings indicate that the molecular subregion(s) responsible for inducing IgE class-restricted tolerance resides in the e heavy chain constant region domain(s) of IgE. When soluble IgE is employed, tolerance induction results from neonatal treatment with doses as low as 2.5 #g per injection per mouse; ceil-bound IgE is considerably more potent, in terms of total dose required, since tolerance results from treatment with as few as 1 × 10 6 cells per injection (per mouse), equivalent to an absolute quantity of 0.2 ng of IgE per injection. This long-term class-specific tolerance appears to be a unique feature of the IgE antibody system, since treatment of mice with monoclonal antibodies of the IgA, IgGl, or IgG2b istoypes, either in soluble or cell-bound form, does not perturb antibody responses of their corresponding isotypes or in the IgE class.
By analyzing the lymphoid cells of IgE-tolerant mice after they reached adulthood, the following observations were made: (a) lymphoid cells from such tolerant mice fail to develop FcR~ ÷ cells upon in vitro stimulation with IgE, as is characteristically observed with lymphoid cells from nontolerant mice; and (b) mice rendered tolerant by neonatal treatment with soluble IgE possess IgE classrestricted suppressor T cells, demonstrable in adoptive transfer experiments, whereas no such suppressor cells are evident in mice in which ceil-bound IgE was used for neonatal treatment. The latter observations could mean that two different mechanisms underlie the IgE class-restricted tolerance, or both mechanisms operate coordinately to varying degrees depending upon which regimen is used for tolerance induction, as discussed herein.
